PBHNYSEPharmaceutical PreparationsFiscal year ends March 31

Prestige Consumer Healthcare Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$49.71−0.21 (-0.42%)

Close on Oct 19, 2026

Market cap: $2.37B
P/E (TTM): 13.9
Dividend yield: –

Prestige Consumer Healthcare Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31	FY 2014 2014-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31	FY 2011 2011-03-31	FY 2010 2010-03-31	FY 2009 2009-03-31
Cash & Equivalents	64	98	46	58	27	32	95	28	33	42	27	21	28	16	19	13	41	35
Cash & Short-Term Investments	64	98	46	58	27	32	95	28	33	42	27	21	28	16	19	13	41	35
Receivables	192	194	177	167	139	115	151	149	141	137	95	88	65	73	73	44	–	–
Inventory	159	148	139	162	120	115	116	120	119	116	91	74	66	60	51	40	–	–
Prepaid Expenses & Other	17	8.44	13	4.12	6.41	7.90	4.35	4.74	12	40	25	10	12	8.90	11	4.81	–	–
Total Current Assets	431	448	375	392	293	270	366	301	303	334	249	202	177	164	147	108	–	–
Property, Plant & Equipment	122	75	77	70	71	70	56	51	53	51	16	14	9.60	9.90	9.90	1.44	–	–
Gross Property, Plant & Equipment	211	156	149	137	132	124	102	90	83	71	30	26	17	14	14	–	–	–
Accumulated Depreciation	-89	-81	-72	-67	-61	-54	-46	-39	-30	-20	-15	-12	-7.85	-4.47	-4.47	–	–	–
Operating Lease Right-of-Use Assets	28	28	11	15	20	24	29	0	–	–	–	–	–	–	–	–	–	–
Goodwill	581	527	528	528	579	578	575	579	620	615	360	291	191	168	174	155	111	–
Intangible Assets	2,300	2,295	2,321	2,342	2,697	2,476	2,479	2,507	2,781	2,904	2,323	2,135	1,395	1,373	1,401	786	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	1.00	1.00	1.00	–	–	–	–	–	–	–	–
Other Long-Term Assets	11	3.27	5.73	3.01	3.27	2.86	2.96	3.13	3.57	7.45	1.32	1.17	23	25	36	6.64	–	–
Total Assets	3,494	3,402	3,318	3,354	3,671	3,429	3,514	3,441	3,761	3,911	2,949	2,642	1,796	1,740	1,758	1,057	–	–
Accounts Payable	23	19	39	63	56	46	62	57	61	70	38	46	48	51	27	22	–	–
Accrued Expenses	–	–	–	–	–	–	–	–	–	–	–	41	26	31	23	22	–	–
Current Portion of Long-Term Debt	0	–	–	–	–	0	–	–	–	–	–	0	0	–	–	–	–	–
Current Debt	0	–	–	–	–	0	–	–	–	–	–	0	0	–	–	–	–	–
Current Portion of Leases	6.91	6.05	4.66	6.93	6.36	5.86	5.61	0	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	0.73	0.83	2.57	11	2.66	1.65	3.21	0.09	1.90	3.84	3.68	2.64	1.85	0.49	0.58	–	–	–
Total Current Liabilities	121	107	117	161	143	122	150	127	123	162	107	99	84	97	64	54	–	–
Long-Term Debt	994	–	1,135	1,346	1,477	1,480	1,730	1,799	1,993	2,194	1,625	1,561	934	971	1,124	487	–	–
Long-Term Leases	21	23	7.53	9.88	16	20	25	0	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	28	29	12	17	22	26	30	0	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	447	420	404	380	445	434	408	400	443	715	470	352	213	194	168	154	–	–
Other Long-Term Liabilities	5.58	5.39	9.19	8.17	7.48	8.61	25	20	23	18	2.84	2.46	0.33	0	–	–	–	–
Total Liabilities	1,607	1,567	1,663	1,907	2,093	2,071	2,343	2,345	2,582	3,089	2,204	2,014	1,232	1,262	1,356	695	–	–
Total Debt	994	–	1,135	1,346	1,477	1,480	1,730	1,799	1,993	2,194	1,625	1,561	934	971	1,124	487	–	–
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–
Common Stock	0.56	0.56	0.56	0.55	0.54	0.54	0.54	0.54	0.53	0.53	0.53	0.53	0.52	0.51	0.51	0.50	–	–
Additional Paid-In Capital	609	593	567	535	516	500	488	479	469	458	445	427	414	402	392	388	–	–
Retained Earnings	1,746	1,556	1,341	1,132	1,214	1,009	844	702	736	397	327	227	149	76	11	-26	–	–
Treasury Stock	-439	-277	-220	-189	-134	-131	-118	-60	-7.67	-6.59	-5.16	-3.48	-1.43	-0.69	-0.69	-0.42	–	–
Comprehensive Income & Other	-28	-38	-34	-32	-19	-20	-44	-26	-19	-26	-24	-23	0.74	-0.10	-0.01	0	–	–
Shareholders' Equity	1,888	1,835	1,655	1,447	1,578	1,358	1,171	1,096	1,179	823	744	628	563	478	403	362	329	294
Total Equity	1,888	1,835	1,655	1,447	1,578	1,358	1,171	1,096	1,179	823	744	628	563	478	403	362	329	294
Total Liabilities & Equity	3,494	3,402	3,318	3,354	3,671	3,429	3,514	3,441	3,761	3,911	2,949	2,642	1,796	1,740	1,758	1,057	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 53.5%
Operating margin: 26.3%
Net margin: 15.6%
Return on equity, FY2026: 10.2%

Financial strength

Current ratio: 3.23
Debt to equity: 1.05
Debt to assets: 44.2%
Cash to current liabilities: 57.9%

Valuation

P/E ratio: 13.9
Price to sales: 2.14
Price to book: 1.23
Dividend yield: –